Bringing the fundamentals into focus…
Back to Strata Critical Medical, Inc.
How Strata Critical Medical, Inc. stacks up
SRTA · against 408 other Healthcare companies of similar size
Profitability
44/ 100
Above the middle of the pack.
Ranked #182 of 409 · scores higher than 55% of peers
Bars: peers in each 10-point band of the profitability score48 peers with a profitability score of 40–49, including SRTA · Click a bar to see the companies
Why profitability scores 44?
Weighted metrics compared with all Healthcare companies.A mix: stronger return on assets, but weaker operating margin and return on invested capital than most Healthcare peers.
- a thinner operating margin: weaker than 74% of peers. Operating margin: -8.0% vs peer median 7.1%
- a lower return on invested capital: weaker than 72% of peers. Return on invested capital: -6.1% vs peer median 4.7%
- a higher return on assets: stronger than 93% of peers. Return on assets: 12.1% vs peer median 1.7%
Metric by metric
Position: dot = SRTA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | SRTA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 378 reported | -6.1% | 0.8% | 35% | 33% | |
| Operating marginHigher is better · 381 reported | -8.0% | 3.4% | 33% | 33% | |
| Return on assetsHigher is better · 407 reported | 12.1% | 0.4% | 96% | 33% | |
| Return on equityHigher is better · 386 reported | -9.2% | -0.2% | 39% | Context only | |
| Gross marginHigher is better · 427 reported | 21.3% | 38.4% | 28% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around SRTA| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 182 | 443.6B KRW (≈$319M) | 44 | 44 | |
| 182 | 4.4B CNY (≈$613M) | 44 | 43 | |
| 182 | 4.3B CNY (≈$596M) | 44 | 56 | |
| 182 | 759M USD | 44 | 54 | |
| 182 | 393M USD | 44 | 61 | |
| 187 | 2.5B CNY (≈$345M) | 43 | 39 | |
| 187 | 3.0B CNY (≈$427M) | 43 | 36 | |
| 187 | 5.8B HKD (≈$739M) | 43 | 44 | |
| 187 | 2.3B CNY (≈$323M) | 43 | 40 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score